Literature DB >> 22453322

Effect of operative technique on mesh exposure in laparoscopic sacrocolpopexy.

William B Warner1, Sonali Vora, Eric A Hurtado, Jeffrey A Welgoss, Nicolette S Horbach, Walter S von Pechmann.   

Abstract

OBJECTIVES: To determine if opening the vaginal cuff during laparoscopic sacrocolpopexy influences the rate of mesh exposure.
METHODS: A total of 390 medical records were retrospectively reviewed for demographic information, operative technique, and relevant outcomes.
RESULTS: Eleven mesh exposures (2.8%) and 14 suture extrusions (3.6%) were found, none involving visceral organs. Mesh exposure was more common when the vaginal cuff was opened, either during hysterectomy or when allowing transvaginal attachment of mesh in patients with a prior hysterectomy (4.9% vs 0.5%; relative risk [RR], 9.0, P = 0.012). In cases where concomitant hysterectomy was performed, a higher mesh exposure rate was seen in open-cuff hysterectomy (total vaginal hysterectomy/laparoscopically assisted vaginal hysterectomy) compared to supracervical hysterectomy (4.9% [9/185] vs 0% [0/92]; P = 0.032). Mesh exposure was more common when the mesh was sutured laparoscopically compared with transvaginally in patients undergoing open-cuff hysterectomy (14.3% [5/35] vs 2.7% [4/150]; RR, 5.4; P = 0.013). Permanent suture extrusion was significantly associated with laparoscopic versus transvaginal suturing of mesh (5.6% vs 0.6%; RR, 8.8; P = 0.010). Five patients underwent reoperation for mesh exposure, whereas most suture extrusions were asymptomatic; and all were managed nonsurgically.
CONCLUSIONS: We found that preserving the integrity of the vaginal cuff led to a lower incidence of mesh exposure in patients undergoing laparoscopic sacrocolpopexy. When hysterectomy is indicated, a supracervical technique should be strongly considered as the mesh exposure rate was significantly lower. If removal of the cervix is indicated, the risk for mesh exposure remains low and should not preclude total hysterectomy, though transvaginal mesh attachment may be preferable.

Entities:  

Mesh:

Year:  2012        PMID: 22453322     DOI: 10.1097/SPV.0b013e318249bd54

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  7 in total

1.  Differences in recurrent prolapse at 1 year after total vs supracervical hysterectomy and robotic sacrocolpopexy.

Authors:  Erinn M Myers; Lauren Siff; Blake Osmundsen; Elizabeth Geller; Catherine A Matthews
Journal:  Int Urogynecol J       Date:  2014-11-01       Impact factor: 2.894

2.  Mesh complications after total vs supracervical laparoscopic hysterectomy at time of minimally invasive sacrocolpopexy.

Authors:  Deepanjana Das; Allison Carroll; Margaret Mueller; Kimberly Kenton; Christina Lewicky-Gaupp; Sarah Collins; Julia Geynisman-Tan; C Emi Bretschneider
Journal:  Int Urogynecol J       Date:  2022-06-06       Impact factor: 1.932

Review 3.  Mesh exposure following minimally invasive sacrocolpopexy: a narrative review.

Authors:  Stephanie Deblaere; Jan Hauspy; Karen Hansen
Journal:  Int Urogynecol J       Date:  2022-02-28       Impact factor: 1.932

4.  Mesh Exposure Following Vaginal Versus Laparoscopic Hysterectomy at the Time of Sacrocolpopexy.

Authors:  Katherine L Woodburn; Amr Sherif El Haraki; Andrew I Sokol; Robert E Gutman; Catherine A Matthews
Journal:  Int Urogynecol J       Date:  2022-02-14       Impact factor: 1.932

5.  The vaginally assisted laparoscopic sacrocolpopexy: a pilot study.

Authors:  Stavros Athanasiou; Themos Grigoriadis; Ioannis Chatzipapas; Athanasios Protopapas; Aris Antsaklis
Journal:  Int Urogynecol J       Date:  2012-10-18       Impact factor: 2.894

Review 6.  Robotic-assisted repair of pelvic organ prolapse: a scoping review of the literature.

Authors:  Jeffrey S Schachar; Catherine A Matthews
Journal:  Transl Androl Urol       Date:  2020-04

Review 7.  Current surgical management of pelvic organ prolapse: Strategies for the improvement of surgical outcomes.

Authors:  Kwang Jin Ko; Kyu-Sung Lee
Journal:  Investig Clin Urol       Date:  2019-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.